SHENZHEN, China, April 10 /Xinhua-PRNewswire-FirstCall/ -- Mindray Medical International Limited (NYSE: MR), a leading developer, manufacturer and marketer of medical devices in China with a rapidly ...

Mountain View, Calif. — Demonstrating the success of its low-power and power-efficient programmable technologies, ActelCorporation today announced that Mindray Medical International Limited, China's ...

Chinese medical devices major Mindray Medical International Limited ( MR) recently revealed that it will showcase over 90 offerings at the 68th China International Medical Equipment Fair (CMEF) to be ...

A company's first international order is often planned and prepared for at great length. But David Yin, managing director of Mindray Medical's European operations, recalled that his team's first ...

Until last year, Mindray Medical International, was spending big to get a foothold in the world’s richest medical market, the U.S., forking over $202 million in March for Datascope’s patient ...

David Yin, managing director of Europe at the Shenzhen-based Mindray Medical International Ltd, recalled that his team's first order from overseas was the result of "an accident". In 2000, a British ...

Medical device developer Mindray today announced a partnership with HealthTrust Purchasing Group to provide anesthesia equipment and supplies for members in 10,600 ambulatory surgery centers and 1,400 ...

Mindray's rapid growth hasn't been all smooth sailing, however. The FDA cited the company late in 2012 for a number of quality system violations regarding its manufacturing of patient monitors and ...

The share price of China's Mindray Medical ($MR) rose 16% last week on the New York Stock Exchange amid rumors that it will be taken over by private equity firms ...

Shenzhen Mindray Bio-Medical Electronics Co., Ltd, a Chinese medical equipment manufacturing company, plans to acquire a controlling stake in APT Medical. This is reported by foreign media. As part of ...

). In the report, Deutsche Bank was positive in its outlook for the companies in terms of their potential growth in the Chinese economy. Deutsche Bank writes, “[Chinese] Government spending is off to ...

As has been widely speculated, senior managers at NYSE-listed China devicemaker Mindray Medical ($MR) offered $30 a share to take the company private, setting a line ...